LWLGLightwave Logic, Inc.
Is the business good?
5 of 9 health tests passed. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is LWLG?
Lightwave Logic, Inc. keeps −9688% of every revenue dollar as operating profit, against 7.4% for the median Specialty Chemicals name.
Operating margin · Specialty Chemicals median 7.4% · 12 months to Q2 2026
- Share count, year on year
- +23%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 5246%
R&D as % of revenue
- Gross margin
- 99%
Gross margin
| Year | Operating margin |
|---|---|
| FY2023 | −52405% |
| FY2024 | −24151% |
| FY2025 | −8765% |
Details›
- Gross margin12 months to Q2 2026
- 99%
- Operating margin12 months to Q2 2026
- −9688%
- Net margin12 months to Q2 2026
- −9134%
- Free cash flow margin
- −7324%
- R&D as % of revenue
- 5246%
- Revenue, trailing twelve months
- $250K
- Free cash flow, trailing twelve months
- −$18M
- Net income, trailing twelve months
- −$23M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Specialty Chemicals
Ranks #32 of 33 by RyuScore